$110.96
0.67% yesterday
NYSE, Nov 25, 10:00 pm CET
ISIN
US98956P1021
Symbol
ZBH

Zimmer Biomet Holdings, Inc. Stock price

$110.96
+8.61 8.41% 1M
-5.45 4.68% 6M
-10.74 8.83% YTD
-2.88 2.53% 1Y
-15.42 12.20% 3Y
-29.79 21.16% 5Y
+3.20 2.97% 10Y
NYSE, Closing price Mon, Nov 25 2024
+0.74 0.67%
ISIN
US98956P1021
Symbol
ZBH
Sector

Key metrics

Market capitalization $22.09b
Enterprise Value $27.98b
P/E (TTM) P/E ratio 21.14
EV/FCF (TTM) EV/FCF 25.46
EV/Sales (TTM) EV/Sales 3.68
P/S ratio (TTM) P/S ratio 2.91
P/B ratio (TTM) P/B ratio 1.79
Dividend yield 0.87%
Last dividend (FY23) $0.96
Revenue growth (TTM) Revenue growth 4.34%
Revenue (TTM) Revenue $7.60b
EBIT (operating result TTM) EBIT $1.44b
Free Cash Flow (TTM) Free Cash Flow $1.10b
Cash position $569.00m
EPS (TTM) EPS $5.25
P/E forward 22.98
P/S forward 2.88
EV/Sales forward 3.65
Short interest 3.82%
Show more

Is Zimmer Biomet Holdings, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Zimmer Biomet Holdings, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

31 Analysts have issued a Zimmer Biomet Holdings, Inc. forecast:

10x Buy
32%
19x Hold
61%
2x Sell
6%

Analyst Opinions

31 Analysts have issued a Zimmer Biomet Holdings, Inc. forecast:

Buy
32%
Hold
61%
Sell
6%

Financial data from Zimmer Biomet Holdings, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
7,596 7,596
4% 4%
100%
- Direct Costs 2,832 2,832
5% 5%
37%
4,764 4,764
4% 4%
63%
- Selling and Administrative Expenses 1,909 1,909
1% 1%
25%
- Research and Development Expense 442 442
2% 2%
6%
2,412 2,412
8% 8%
32%
- Depreciation and Amortization 974 974
4% 4%
13%
EBIT (Operating Income) EBIT 1,438 1,438
11% 11%
19%
Net Profit 1,083 1,083
128% 128%
14%

In millions USD.

Don't miss a Thing! We will send you all news about Zimmer Biomet Holdings, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Zimmer Biomet Holdings, Inc. Stock News

Neutral
PRNewsWire
about 15 hours ago
WARSAW, Ind., Nov. 25, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) Premarket Approval Application (PMA) Supplement approval for the Oxford® Cementless Partial Knee.
Neutral
PRNewsWire
5 days ago
WARSAW, Ind. , Nov. 21, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will participate in the Citi Global Healthcare Conference on December 5, 2024, with a fireside chat at 8:45 a.m.
Neutral
PRNewsWire
8 days ago
WARSAW, Ind., and ZURICH , Nov. 18, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE: ZBH and SIX: ZBH), a global medical technology leader, today received the CE Mark for its Persona® Revision Knee System.
More Zimmer Biomet Holdings, Inc. News

Company Profile

Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare services. It designs, manufactures and markets orthopedic reconstructive products, sports medicine, biologics, extremities & trauma products, office based technologies, spine, craniomaxillofacial & thoracic products, dental implants and related surgical products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Zimmer Biomet Holdings was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Head office United States
CEO Ivan Tornos
Employees 18,000
Founded 1927
Website www.zimmerbiomet.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today